Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages

Infection and Immunity

Volumn 80, Issue 12, 2012, Pages 4426-4434

  Li, Wei ^a   Katz, Barry P ^a   Spinola, Stanley M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CELL SURFACE MARKER; CHEMOKINE; CYTOKINE; INTERLEUKIN 10; MDM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SCAVENGER RECEPTOR A; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HAEMOPHILUS DUCREYI; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE POLARIZATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PUSTULE; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SKIN BIOPSY; ULCUS MOLLE;

ADULT; BIOPSY; CHANCROID; CYTOKINES; FEMALE; HAEMOPHILUS DUCREYI; HUMANS; INTERLEUKIN-10; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; RECEPTORS, CELL SURFACE; SKIN; YOUNG ADULT;

EID: 84870821865     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00912-12     Document Type: Article

References (51)

1. Al-Tawfiq JA, Spinola SM. 2002. Haemophilus ducreyi: clinical disease and pathogenesis. Curr. Opin. Infect. Dis. 15:43-47.
2. Al-Tawfiq JA, et al. 1998. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J. Infect. Dis. 178:1684-1687.
3. Ambarus CA, et al. 2012. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J. Immunol. Methods 375:196-206.
4. Banks KE, et al. 2008. The enterobacterial common antigen-like gene cluster of Haemophilus ducreyi contributes to virulence in humans. J. Infect. Dis. 197:1531-1536.
5. Banks KE, et al. 2007. Haemophilus ducreyi partially activates human myeloid dendritic cells. Infect. Immun. 75:5678-5685.
6. Bauer ME, Goheen MP, Townsend CA, Spinola SM. 2001. Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers. Infect. Immun. 69:2549-2557.
7. Bauer ME, Townsend CA, Ronald AR, Spinola SM. 2006. Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. Microbes Infect. 8:2465-2468.
8. Bellora F, et al. 2010. The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc. Natl. Acad. Sci. U. S. A. 107:21659-21664.
9. Benoit M, Barbarat B, Bernard A, Olive D, Mege JL. 2008. Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages. Eur. J. Immunol. 38:1065-1070.
10. Benoit M, Desnues B, Mege JL. 2008. Macrophage polarization in bacterial infections. J. Immunol. 181:3733-3739.
11. Bowdish DM, Gordon S. 2009. Conserved domains of the class A scavenger receptors: evolution and function. Immunol. Rev. 227:19-31.
12. Desnues B, Lepidi H, Raoult D, Mege JL. 2005. Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2/alternatively activated macrophages. J. Infect. Dis. 192:1642-1646.
13. Fabriek BO, et al. 2009. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 113:887-892.
14. Fadok VA, McDonald PP, Bratton DL, Henson PM. 1998. Regulation of macrophage cytokine production by phagocytosis of apoptotic and postapoptotic cells. Biochem. Soc. Trans. 26:653-656.
15. Fusco WG, et al. 2010. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge. Infect. Immun. 78:3763-3772.
16. Gelfanova V, Humphreys TL, Spinola SM. 2001. Characterization of Haemophilus ducreyi-specific T cell lines from lesions of experimentally infected human subjects. Infect. Immun. 69:4224-4231.
17. Gordon S, Martinez FO. 2010. Alternative activation of macrophages:mechanism and functions. Immunity 32:593-604.
18. Humphreys T, et al. 2007. Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers. Infect. Immun. 75:5686-5697.
19. Humphreys TL, et al. 2002. Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. J. Immunol. 169:6316-6323.
20. Janowicz DM, et al. 2004. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers. Infect. Immun. 72:4528-4533.
21. Janowicz DM, Ofner S, Katz BP, Spinola SM. 2009. Experimental infection of human volunteers with Haemophilus ducreyi: 15 years of clinical data and experience. J. Infect. Dis. 199:1671-1679.
22. Jouanguy E, et al. 1999. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. Curr. Opin. Immunol.11:346-351.
23. Krysko O, et al. 2011. Alternatively activated macrophages and impaired phagocytosis of S. aureus in chronic rhinosinusitis. Allergy 66:396-403.
24. Leung SY, et al. 2004. Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology 127:457-469.
25. Li W, Janowicz DM, Fortney KR, Katz BP, Spinola SM. 2009. Mechanism of human natural killer cell activation by Haemophilus ducreyi. J. Infect. Dis. 200:590-598.
26. Li W, et al. 2010. Role played by CD4+FOXP3+ regulatory T cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers. J. Infect. Dis. 201:1839-1848.
27. Mantovani A, et al. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677-686.
28. Martinez FO, Helming L, Gordon S. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol.27:451-483.
29. McBride WJ, Hannah RC, Le Cornec GM, Bletchly C. 2008. Cutaneous chancroid in a visitor from Vanuatu. Australas. J. Dermatol. 49:98-99.
30. Mege JL, Mehraj V, Capo C. 2011. Macrophage polarization and bacterial infections. Curr. Opin. Infect. Dis. 24:230-234.
31. Mock JR, et al. 2005. Haemophilus ducreyi targets Src family protein tyrosine kinases to inhibit phagocytic signaling. Infect. Immun. 73:7808-7816.
32. Montoya D, et al. 2009. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6:343-353.
33. Moos V, et al. 2010. Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology 138:210-220.
34. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
35. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. 2005. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182:1-15.
36. Odumeru JA, Wiseman GM, Ronald AR. 1985. Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum. Infect. Immun. 50:495-499.
37. Palmer KL, et al. 1998. The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. J. Infect. Dis. 178:1688-1697.
38. Peel TN, Bhatti D, De Boer JC, Stratov I, Spelman DW. 2010. Chronic cutaneous ulcers secondary to Haemophilus ducreyi infection. Med. J.Aust. 192:348-350.
39. Peiser L, Gough PJ, Kodama T, Gordon S. 2000. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect. Immun. 68:1953-1963.
40. Pinheiro da Silva F, et al. 2007. CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat. Med. 13:1368-1374.
41. Quiding-Jarbrink M, Raghavan S, Sundquist M. 2010. Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice. PLoS One 5:e15018. doi:10.1371/journal.pone.0015018.
42. Rinker SD, et al. 12 September 2012. Permeases of the Sap transporter are required for cathelicidin resistance and virulence of Haemophilus ducreyi in humans. J. Infect. Dis. [Epub ahead of print.] doi:10.1093/infdis/jis525.
43. Saraiva M, O'Garra A. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10:170-181.
44. Sica A, Mantovani A. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122:787-795.
45. Spinola SM. 2008. Chancroid and Haemophilus ducreyi, p 689-699. In Holmes KK, et al (ed), Sexually transmitted diseases, 4th ed. McGraw-Hill, New York, NY.
46. Spinola SM, Bauer ME, Munson RS Jr. 2002. Immunopathogenesis of Haemophilus ducreyi infection (chancroid). Infect. Immun. 70:1667-1676.
47. Spinola SM, Wild LM, Apicella MA, Gaspari AA, Campagnari AA.1994. Experimental human infection with Haemophilus ducreyi. J. Infect. Dis. 169:1146-1150.
48. Sulahian TH, Imrich A, Deloid G, Winkler AR, Kobzik L. 2008. Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Respir. Res. 9:59.
49. Ussher JE, Wilson E, Campanella S, Taylor SL, Roberts SA. 2007.Haemophilus ducreyi causing chronic skin ulceration in children visiting Samoa. Clin. Infect. Dis. 44:e85-87.
50. Vakevainen M, Greenberg S, Hansen EJ. 2003. Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins. Infect. Immun. 71:5994-6003.
51. van der Laan LJ, et al. 1999. Regulation and functional involvement of macrophage scavenger receptorMARCOin clearance of bacteria in vivo. J.Immunol. 162:939-947.